Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

The ongoing evolution of Medical Affairs

April 14, 2023 | #COVID19, AI, Eddie Power, Healthcare Technology, Impetus Digital, Medical Affairs Pharma, Medical Affairs Teams, Natalie Yeadon, Pfizer, bioethics, blockchain, data privacy, machine learning, medical affairs, pharma technology, silico trials 

In the latest episode of Impetus Digital’s Fireside Chat series, Natalie Yeadon, Co-Founder and CEO of Impetus Digital talks to Eddie Power, Vice President of North America Medical Affairs, Hospital Business at Pfizer.They discuss a range of topics, including the effects of COVID-19 on the way Medical Affairs teams work and interact with the healthcare community. They also delve into the concept of ‘systems thinking’ and how this line of thinking can be applied within Medical Affairs and Pharma as a whole. Further, Eddie gives his thoughts on the role of technology in applying systems thinking, including barriers such as concerns about data privacy and bioethics. Other topics explored include innovative concepts such as in silico trials, AI and machine learning, and blockchain.

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Courageous Conversation ep.11: How to Inspire Creativity with Virtual Working Groups

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on how to inspire creativity with virtual working groups.

Parallel HCP-Patient Advisory Boards: A Customer Story

Learn how a Pharma team engaged both dermatologists and patients with psoriasis in two parallel virtual advisory boards.

Courageous Conversation ep.10: Facial Recognition Software in Healthcare

Natalie Yeadon, Co-Founder & CEO at Impetus Digital, provides insight on Facial Recognition Software in Healthcare.

Transforming the Future of Health & Aging from a Global Health & Social Impact Approach

Dr. Zayna Khayat, Future Strategist at SE Health, dives into the future of aging and healthcare in Canada, including the roles of emerging technologies, the shift to people-powered healthcare, and…

Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery

Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve…

Top-10 ways that Pharma teams can fight the climate crisis

Ten easy steps that individual medical, marketing, clinical, regulatory, and market access teams can take to reduce their own footprints.

Revolutionizing 3D Bioprinting & Disrupting the Drug Development Industry

Christine Whiteside, COO of VoxCell BioInnovation, discusses 3D bioprinting, including current and future applications and key barriers to realizing its full potential. She also shares her tips for getting new…

It Takes 5 to Tango: The 5 Ps in Healthcare

Dr. Verena Voelter, Founder & Managing Director at 5P Health Care Solutions, explores collaborative value-based healthcare models, the role of digital transformation in enabling new forms of patient-centric and value-generating…

Blockchain for Tracking and Validating Medical Cannabis

Robert Galarza, CEO of TruTrace Technologies, Inc., dives into the use of blockchain technology for verifying medical cannabis products and protecting intellectual property. He also shares his leadership tips and…

Improving Health Through Integrated & Personalized Patient Care

Hicham Naim, Global Head, Integrated & Personalized Patient Care Program, Digital Advisory Board at Takeda & Founder of Curated Health, explores digital medicine & biomarkers, outcomes-based business models, Software as…